Valganciclovir hydrochloride

This classification denotes the hydrochloride form of a purine antagonist and antiviral agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GCU97FKN3R. European Medicines Agency schedules Valganciclovir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00007MIG. Valganciclovir generally arises in the molecular formula C14H22N6O5. The term VALGANCICLOVIR is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 12 no. 2 1999, list 40.) VALGANCICLOVIR is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule valganciclovir hydrochloride under HS 29335995 and SITC 51576. Valganciclovir hydrochloride bears US NLM identifiers UMLS ID C0969586 and NCI Concept Code C66648. SMILES: As of Q4 2014, VALGANCICLOVIR HYDROCHLORIDE remains US FDA's Preferred Term for this commodity.